Advances in medical imaging for the diagnosis and management of common genitourinary cancers

Mohammad H. Bagheri, Mark A. Ahlman, Liza Lindenberg, Baris Turkbey, Jeffrey Lin, Ali Cahid Civelek, Ashkan A. Malayeri, Piyush K. Agarwal, Peter L. Choyke, Les R. Folio, Andrea B. Apolo

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations


Medical imaging of the 3 most common genitourinary (GU) cancers—prostate adenocarcinoma, renal cell carcinoma, and urothelial carcinoma of the bladder—has evolved significantly during the last decades. The most commonly used imaging modalities for the diagnosis, staging, and follow-up of GU cancers are computed tomography, magnetic resonance imaging (MRI), and positron emission tomography (PET). Multiplanar multidetector computed tomography and multiparametric MRI with diffusion-weighted imaging are the main imaging modalities for renal cell carcinoma and urothelial carcinoma, and although multiparametric MRI is rapidly becoming the main imaging tool in the evaluation of prostate adenocarcinoma, biopsy is still required for diagnosis. Functional and molecular imaging using 18-fluorodeoxyglucose-PET and sodium fluoride-PET are essential for the diagnosis, and especially follow-up, of metastatic GU tumors. This review provides an overview of the latest advances in the imaging of these 3 major GU cancers.

Original languageEnglish (US)
Pages (from-to)473-491
Number of pages19
JournalUrologic Oncology: Seminars and Original Investigations
Issue number7
StatePublished - Jul 2017
Externally publishedYes


  • Bladder urothelial carcinoma
  • CT
  • MRI
  • PET
  • Prostate adenocarcinoma
  • Renal cell carcinoma

ASJC Scopus subject areas

  • Oncology
  • Urology


Dive into the research topics of 'Advances in medical imaging for the diagnosis and management of common genitourinary cancers'. Together they form a unique fingerprint.

Cite this